News | Atrial Fibrillation

The Heart Rhythm Society (HRS), in partnership with WebMD Education, announced in December the launch of a free, online educational tool called “How to Reduce Your Risk of Stroke Due to AFib.” The new tool is part of a larger series of educational activities hosted by WebMD Education to help patients, caregivers and those who may be at risk to learn more about various medical conditions. The AFib-focused tool is an easy-to-use, interactive activity delivering important information straight into the hands of the user. This is the first collaboration between HRS and WebMD Education.

Home January 02, 2018
Home
News | Peripheral Artery Disease (PAD)

December 29, 2017 — iVascular announced the release of the new Oceanus 14 Pro percutaneous transluminal angioplasty (PTA ...

Home December 29, 2017
Home
Videos | Cardiac Imaging

ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the ...

Home December 29, 2017
Home
News | Vascular Closure Devices

Vivasure Medical announced in October the successful enrollment of the first patient in the Frontier IV clinical study, a non-randomized multicenter international trial, designed to expand the indications of the PerQseal large arteriotomy closure technology. The patient was enrolled by Peter Crean, M.D., at the Blackrock Clinic, Dublin, Ireland.

Home December 29, 2017
Home
Biosense Webster multi-electrode ablation balloon.
Feature | Dave Fornell

The Diagnostic and Interventional Cardiology (DAIC) website had another record year with 1.4 million page views in 2017 ...

Home December 28, 2017
Home
News | Robotic Systems

Corindus Vascular Robotics Inc. announced recently that Houston Methodist DeBakey Heart & Vascular Center has launched the first vascular robotic program in the Houston area with the installation of two Corindus CorPath GRX Systems. In addition and as part of the program launch, Corindus will partner with Houston Methodist to develop a Global Center of Excellence that will seek to advance clinical research on robotics and to train interventional cardiologists on robotic-assisted percutaneous coronary interventions (PCI).

Home December 28, 2017
Home
News | Wearables

December 28, 2017 — Zoll Medical Corp. and Myant, Inc., a high-tech advanced manufacturing company, announced they have ...

Home December 28, 2017
Home
News | FFR Technologies

HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five states, has issued a medical policy for the HeartFlow FFRct Analysis, a non-invasive technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). HCSC — which operates Blue Cross Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas — has determined that the use of noninvasive fractional flow reserve (FFR) following a positive coronary computed tomography (CT) angiogram may be considered medically necessary to guide decisions about the use of invasive coronary angiography in patients with stable chest pain at intermediate risk of CAD.

Home December 28, 2017
Home
News | Population Health

Philips recently announced that it acquired VitalHealth, a provider of cloud-based population health management solutions for the delivery of personalized care outside of the hospital, for example, in regional care networks. Headquartered in the Netherlands, VitalHealth’s products and services are being used by more than 100 healthcare networks in various countries including the United States, India, China, Sweden, Germany, Belgium and the Netherlands. The company was founded in 2006 by Mayo Clinic (U.S.) and Noaber Foundation (the Netherlands) and employs approximately 200 employees. Financial details of the transaction were not disclosed.

Home December 28, 2017
Home
News | Heart Failure

December 22, 2017 — To help streamline treatment of patients with heart failure and ensure the best possible patient ...

Home December 22, 2017
Home
News | Vascular Closure Devices

Essential Medical announced the completion of enrollment in the U.S. pivotal investigational device exemption (IDE) trial of the Manta large bore vascular closure device. The company said it has enrolled 341 patients at 21 different sites with 43 investigators in 10 months. Essential Medical President and CEO Greg Walters said the company expects to file a premarket approval (PMA) submission with the U.S. Food and Drug Administration (FDA) by the end of the first quarter in 2018.

Home December 22, 2017
Home
News | Cardiovascular Ultrasound

December 21, 2017 — Bay Labs, a medical technology company applying artificial intelligence (AI) to cardiovascular ...

Home December 21, 2017
Home
News | Cardiovascular Business

The Centers for Medicare & Medicaid Services (CMS) last week finalized the cancellation of the mandatory hip fracture and cardiac bundled payment models that were to be operated by the CMS Innovation Center and implemented changes to the Comprehensive Care for Joint Replacement (CJR) Model. These changes will offer greater flexibility and choice for hospitals in providing care to Medicare patients.

Home December 21, 2017
Home
News | Medical 3-D Printing

Philips recently announced agreements with 3D Systems and Stratasys, two global leaders in the 3-D printing industry, to help progress patient care and improve the clinician experience. Advanced 3-D modeling provides radiologists with additional views to help strengthen anatomical knowledge which could enhance clinical impact in reviewing complex, multi-disciplinary cases.

Home December 21, 2017
Home
News | ECMO Systems

A team of researchers at the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, U.K., has been awarded €6.5 million from the Horizon 2020 European Commission fund. The team — a partnership between Leicester’s Hospitals, the University of Leicester and Loughborough University, and led by clinical scientist consultant Prof. Anthony Gershlick from the university’s Department of Cardiovascular Sciences — will investigate the impact of using extracorporeal membrane oxygenation (ECMO) on the outcomes of patients who have had a severe heart attack.

Home December 19, 2017
Home
Subscribe Now